Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

1.

Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.

Ko HS, von Coelln R, Sriram SR, Kim SW, Chung KK, Pletnikova O, Troncoso J, Johnson B, Saffary R, Goh EL, Song H, Park BJ, Kim MJ, Kim S, Dawson VL, Dawson TM.

J Neurosci. 2005 Aug 31;25(35):7968-78.

PMID:
16135753
[PubMed - indexed for MEDLINE]
Free Article
2.

The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.

Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, Prigent A, Robinson JC, Pradier L, Ruberg M, Mirande M, Hirsch E, Rooney T, Fournier A, Brice A.

Hum Mol Genet. 2003 Jun 15;12(12):1427-37.

PMID:
12783850
[PubMed - indexed for MEDLINE]
Free Article
3.

Identification of far upstream element-binding protein-1 as an authentic Parkin substrate.

Ko HS, Kim SW, Sriram SR, Dawson VL, Dawson TM.

J Biol Chem. 2006 Jun 16;281(24):16193-6. Epub 2006 May 3.

PMID:
16672220
[PubMed - indexed for MEDLINE]
Free Article
4.

Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.

Wang HQ, Imai Y, Inoue H, Kataoka A, Iita S, Nukina N, Takahashi R.

J Neurochem. 2008 Oct;107(1):171-85. doi: 10.1111/j.1471-4159.2008.05607.x. Epub 2008 Aug 7.

PMID:
18691389
[PubMed - indexed for MEDLINE]
5.

Pael receptor, endoplasmic reticulum stress, and Parkinson's disease.

Takahashi R, Imai Y.

J Neurol. 2003 Oct;250 Suppl 3:III25-9. Review.

PMID:
14579121
[PubMed - indexed for MEDLINE]
6.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
[PubMed - indexed for MEDLINE]
7.

Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.

Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM.

Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16691-6. doi: 10.1073/pnas.1006083107. Epub 2010 Sep 7.

PMID:
20823226
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.

Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ.

Science. 2001 Jul 13;293(5528):263-9. Epub 2001 Jun 28.

PMID:
11431533
[PubMed - indexed for MEDLINE]
Free Article
9.

Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

Sriram SR, Li X, Ko HS, Chung KK, Wong E, Lim KL, Dawson VL, Dawson TM.

Hum Mol Genet. 2005 Sep 1;14(17):2571-86. Epub 2005 Jul 27.

PMID:
16049031
[PubMed - indexed for MEDLINE]
Free Article
10.

Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.

von Coelln R, Thomas B, Andrabi SA, Lim KL, Savitt JM, Saffary R, Stirling W, Bruno K, Hess EJ, Lee MK, Dawson VL, Dawson TM.

J Neurosci. 2006 Apr 5;26(14):3685-96.

PMID:
16597723
[PubMed - indexed for MEDLINE]
Free Article
11.

[Neurodegeneration caused by ER stress?--the pathogenetic mechanisms underlying AR-JP].

Takahashi R.

Nihon Yakurigaku Zasshi. 2004 Dec;124(6):375-82. Japanese.

PMID:
15572841
[PubMed - indexed for MEDLINE]
12.

Parkin and defective ubiquitination in Parkinson's disease.

Dawson TM.

J Neural Transm Suppl. 2006;(70):209-13. Review.

PMID:
17017531
[PubMed - indexed for MEDLINE]
13.

Parkin and endoplasmic reticulum stress.

Takahashi R, Imai Y, Hattori N, Mizuno Y.

Ann N Y Acad Sci. 2003 Jun;991:101-6. Review.

PMID:
12846978
[PubMed - indexed for MEDLINE]
14.

Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.

Machida Y, Chiba T, Takayanagi A, Tanaka Y, Asanuma M, Ogawa N, Koyama A, Iwatsubo T, Ito S, Jansen PH, Shimizu N, Tanaka K, Mizuno Y, Hattori N.

Biochem Biophys Res Commun. 2005 Jun 24;332(1):233-40. Erratum in: Biochem Biophys Res Commun. 2005 Sep 2;334(3):970.

PMID:
15896322
[PubMed - indexed for MEDLINE]
15.

How does parkin ligate ubiquitin to Parkinson's disease?

Kahle PJ, Haass C.

EMBO Rep. 2004 Jul;5(7):681-5. Review.

PMID:
15229644
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.

Omura T, Kaneko M, Okuma Y, Orba Y, Nagashima K, Takahashi R, Fujitani N, Matsumura S, Hata A, Kubota K, Murahashi K, Uehara T, Nomura Y.

J Neurochem. 2006 Dec;99(6):1456-69. Epub 2006 Oct 24.

PMID:
17059562
[PubMed - indexed for MEDLINE]
17.

Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.

Jiang H, Ren Y, Zhao J, Feng J.

Hum Mol Genet. 2004 Aug 15;13(16):1745-54. Epub 2004 Jun 15.

PMID:
15198987
[PubMed - indexed for MEDLINE]
Free Article
18.

Parkin is linked to the ubiquitin pathway.

Tanaka K, Suzuki T, Chiba T, Shimura H, Hattori N, Mizuno Y.

J Mol Med (Berl). 2001 Sep;79(9):482-94. Review.

PMID:
11692161
[PubMed - indexed for MEDLINE]
19.

Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.

Hampe C, Ardila-Osorio H, Fournier M, Brice A, Corti O.

Hum Mol Genet. 2006 Jul 1;15(13):2059-75. Epub 2006 May 19.

PMID:
16714300
[PubMed - indexed for MEDLINE]
Free Article
20.

Parkin-associated Parkinson's disease.

von Coelln R, Dawson VL, Dawson TM.

Cell Tissue Res. 2004 Oct;318(1):175-84. Epub 2004 Jul 30. Review.

PMID:
15503153
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk